<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343132">
  <stage>Registered</stage>
  <submitdate>29/06/2011</submitdate>
  <approvaldate>3/08/2011</approvaldate>
  <actrnumber>ACTRN12611000815965</actrnumber>
  <trial_identification>
    <studytitle>Using a biodegradable polyurethane foam in comparison with Granufoam (black, non-biodegradable foam) with Vacuum-Assisted Closure in the management of decubitus ulcers (pressure sores)</studytitle>
    <scientifictitle>Safety and efficacy of vacuum assisted closure with a biodegradable polyurethane foam versus Granufoam in pressure sore sufferers.</scientifictitle>
    <utrn>Nil</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pressure sores (decubitus ulceration)</healthcondition>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Other skin conditions</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>New biodegradable polyurethane foam under topical negative pressure in standard treatment regimen (foams changed every 2-3 days) for 8 weeks.</interventions>
    <comparator>Commercially-available non-biodegradable polyurethane foam under topical negative pressure in standard treatment regimen (foams changed every 2-3 days) for 8 weeks.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Ability to transmit topical negative pressure to the wound bed (assessed by odour, reduction of oedema, development of vascular granulations, cleanliness, wound area) with assessment by an independent specialist woundcare nurse, photographic analysis and wound area measurement.</outcome>
      <timepoint>Every 2-3 days for 8 weeks.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Safety (assessed by absence of local or systemic effects attributable to the new material). This can only be assessed by direct comparison with the control material, both within the study and against historical experience.</outcome>
      <timepoint>Every 2-3 days for 8 weeks.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Ischial or sacral pressure sore; &gt;18 years old; suitable for topical negative pressure after wound debridement; able to provide informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnancy; inability to provide informed consent</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Enrollment in community and hospital wound clinics after consultation with wound specialist and open discussion of the trial objectives and course. Allocation to foam type by random numbers generated in sealed envelopes.</concealment>
    <sequence>Computerised sequence generation</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/09/2011</anticipatedstartdate>
    <actualstartdate>4/03/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate>24/01/2013</actualenddate>
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>NovoWound Pty Ltd</primarysponsorname>
    <primarysponsoraddress>Unit 2, 320 Lorimer Street, Port Melbourne 3207, Victoria</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>NovoWound Pty Ltd</fundingname>
      <fundingaddress>Unit 2, 320 Lorimer Street, Port Melbourne 3207, Victoria</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Royal Adelaide Hospital</sponsorname>
      <sponsoraddress>North Terrace, Adelaide 5000, South Australia</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Other Collaborative groups</othercollaboratortype>
      <othercollaboratorname>Royal District Nursing Service</othercollaboratorname>
      <othercollaboratoraddress>1, Richmond Road, Keswick 5035, South Australia</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Comparison of new biodegradable foam against commercially available non-biodegradable foam under topical negative pressure dressings for safety and efficacy in transmitting the vacuum to the wound bed.</summary>
    <trialwebsite />
    <publication>- Li A, Dearman BL, Crompton KE, Moore TG, Greenwood JE. Evaluation of a novel biodegradable polymer for the generation of a dermal matrix. Journal of Burn Care and Research 2009;30(4):717-728.
- Greenwood JE, Li A, Dearman BL, Moore TG. Evaluation of NovoSorb novel biodegradable polymer for the generation of a dermal matrix. Part 1: In-vitro studies. Wound Practice and Research 2010;18(1):14-22.
- Greenwood JE, Li A, Dearman BL, Moore TG. Evaluation of NovoSorb novel biodegradable polymer for the generation of a dermal matrix. Part 2: In-vivo studies. Wound Practice and Research 2010;18(1):24-34.
- Greenwood JE. Biodegradable polyurethane as a dermal matrix. Journal of Burn Care and Research 2011; 32(2) (supplement):S58.
- Greenwood JE, Dearman BL. Split-skin graft application over an integrating, biodegradable temporising polymer matrix: Immediate and delayed. Journal of Burn Care and Research (accepted).
- Greenwood JE, Dearman BL. Comparison of a sealed, NovoSorb biodegradable temporising matrix (BTM) against Integra: a prospective, porcine study. Journal of Burn Care and Research (accepted).</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Adelaide Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Level 3, Hanson Institute (IMVS Building)
Royal Adelaide Hospital, North Terrace, Adelaide 5000, South Australia</ethicaddress>
      <ethicapprovaldate>23/06/2011</ethicapprovaldate>
      <hrec>110612</hrec>
      <ethicsubmitdate>16/06/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>John E Greenwood</name>
      <address>Adult Burn Centre, Royal Adelaide Hospital, North Terrace, Adelaide 5000, South Australia</address>
      <phone>+61 8 8222 2233</phone>
      <fax>+61 8 8222 2233</fax>
      <email>john.greenwood@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>John E Greenwood</name>
      <address>Adult Burn Centre, Royal Adelaide Hospital, North Terrace, Adelaide 5000, South Australia</address>
      <phone>+61 8 8222 2233</phone>
      <fax>+61 8 8222 5676</fax>
      <email>john.greenwood@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>John E Greenwood</name>
      <address>Adult Burn Centre, Royal Adelaide Hospital, North Terrace, Adelaide 5000, South Australia</address>
      <phone>+61 8 8222 2233</phone>
      <fax>+61 8 8222 2233</fax>
      <email>john.greenwood@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>John E Greenwood</name>
      <address>Adult Burn Centre, Royal Adelaide Hospital, North Terrace, Adelaide 5000 South Australia</address>
      <phone>+61 8 8222 2233</phone>
      <fax>+61 8 8222 5676</fax>
      <email>john.greenwood@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>